Clinical Trial

Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 25, 2025 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to determine the effect of pregabalin versus dexmedetomidine on the treatment and lasting duration of delirium in fast tracking elderly patients after Coronary Artery Bypass Grafting.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-12-06; most recent amendment 2025-06-23.
Status change: Not Yet Recruiting → Recruiting 2023-04-15
Trial Details
NCT Number NCT05640453
Lead Sponsor Tanta University
Conditions Pregabalin, Delirium Treatment, Coronary Artery Bypass Grafting, Dexmedetomidine
Enrollment 70 participants
Start Date 2022-12-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2025-06-25